Neuroscientists have developed a statistical framework that rigorously describes the brain state changes that patients experience under ketamine-induced anesthesia. By developing the first statistical ...

In a conversation with International Business Times' Visionary Voices series, Nikita Tsimmer, co-founder of Fountain Health, ...

New research demonstrates the effectiveness of ketamine to treat depression in a mouse model of the disease and brings together two hypotheses for the cause of depression. The research, led by ...

University of Arizona researchers have revealed new insights into the neurobiological cause of the involuntary, uncontrollable movement disorders that develop in patients with Parkinson’s disease (PD) ...

In recent years, media reports touting ketamine as a fast-acting, highly effective treatment for severe depression have increased. In part, this phenomenon is due to the US Food and Drug ...

Ketamine is a short-acting general anesthetic that’s been around since the 1970s. It was first used in the United States for sedation and pain management during the Vietnam War. It continues to have ...

A first-of-its-kind clinical trial found that ketamine’s benefits for treating severe depression can be improved when combined with psychotherapy and supportive treatment environments. Led by ...

Based on brain rhythm measurements from nine human and two animal subjects, the new model published in PLOS Computational Biology defines the distinct, characteristic states of brain activity that ...